José G B Derraik Selected Research

Cesarean Section (Caesarean Section)

7/2021	Oral administration of maternal vaginal microbes at birth to restore gut microbiome development in infants born by caesarean section: A pilot randomised placebo-controlled trial.
7/2020	Maternal bacteria to correct abnormal gut microbiota in babies born by C-section.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

José G B Derraik Research Topics

Disease

20	Insulin Resistance 01/2021 - 01/2012
7	Obesity 01/2021 - 01/2018
6	Overweight 12/2020 - 01/2013
4	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 02/2021 - 03/2012
3	Pediatric Obesity 07/2020 - 01/2020
3	Traumatic Brain Injuries (Traumatic Brain Injury) 10/2016 - 09/2012
3	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2013 - 01/2012
2	Birth Weight (Birth Weights) 01/2019 - 01/2015
1	Cystic Fibrosis (Mucoviscidosis) 01/2022
1	COVID-19 01/2022
1	Disease Susceptibility (Diathesis) 07/2021
1	Sudden Infant Death (SID) 02/2021
1	Down Syndrome (Down's Syndrome) 01/2021
1	Cardiomyopathies (Cardiomyopathy) 01/2021
1	Dysbiosis 01/2021
1	Asthma (Bronchial Asthma) 07/2020
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2020
1	Necrotizing Enterocolitis 01/2020
1	Clostridium Infections 01/2020
1	Infections 01/2020
1	Non-alcoholic Fatty Liver Disease 01/2020
1	Metabolic Diseases (Metabolic Disease) 01/2020
1	Type 2 Diabetes Mellitus (MODY) 01/2020
1	Communicable Diseases (Infectious Diseases) 01/2018
1	Camurati-Engelmann Syndrome (Progressive Diaphyseal Dysplasia) 11/2014
1	Pain (Aches) 11/2014
1	Congenital Hypothyroidism (Cretinism) 09/2013
1	Hyperemesis Gravidarum 08/2013
1	Craniocerebral Trauma (Head Injury) 09/2012
1	Precocious Puberty 02/2012
1	Malnutrition (Nutritional Deficiencies) 02/2012
1	Urticaria (Hives) 05/2010
1	Bites and Stings (Sting) 05/2010
1	Fetal Growth Retardation (Intrauterine Growth Retardation) 01/2010

Drug/Important Bio-Agent (IBA)

14	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 01/2012
9	Insulin (Novolin)FDA Link 02/2021 - 01/2010
5	LipidsIBA 01/2021 - 01/2012
3	Fish OilsIBA 12/2020 - 01/2016
3	Anti-Bacterial Agents (Antibiotics)IBA 01/2020 - 01/2018
2	Docosahexaenoic AcidsIBA 07/2015 - 10/2014
2	Eicosapentaenoic AcidIBA 07/2015 - 10/2014
1	Biomarkers (Surrogate Marker)IBA 02/2021
1	OligosaccharidesIBA 01/2020
1	SteroidsIBA 01/2020
1	Hemoglobins (Hemoglobin)IBA 11/2019
1	Triglycerides (Triacylglycerol)IBA 01/2019
1	Insulin-Like Growth Factor I (IGF-1)IBA 01/2019
1	16S Ribosomal RNAIBA 01/2019
1	Growth Hormone (Somatotropin)IBA 01/2019
1	Blood Glucose (Blood Sugar)IBA 07/2017
1	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 01/2017
1	OilsIBA 01/2017
1	Thyrotropin (Thyroid-Stimulating Hormone)FDA Link 03/2016
1	salmon oilIBA 07/2015
1	Rapeseed OilIBA 07/2015
1	Losartan (Cozaar)FDA LinkGeneric 11/2014
1	hypoiodous acid (HOI)IBA 10/2014
1	Thyroxine (Levothyroxine)FDA LinkGeneric 09/2013
1	AdiponectinIBA 01/2013
1	PolyphenolsIBA 01/2013
1	3,4-dihydroxyphenylethanol (hydroxytyrosol)IBA 01/2013
1	oleuropeinIBA 01/2013
1	Uric Acid (Urate)IBA 01/2013
1	LeptinIBA 01/2013
1	Hydrocortisone (Cortisol)FDA LinkGeneric 09/2012
1	Hormones (Hormone)IBA 02/2012
1	Taurine FDA Link 02/2012
1	Psyllium (Metamucil)IBA 01/2012
1	Messenger RNA (mRNA)IBA 01/2010

Therapy/Procedure

3	Therapeutics 01/2021 - 03/2012
2	Cesarean Section (Caesarean Section) 07/2021 - 07/2020
1	Mechanical Ventilators (Ventilator) 01/2022
1	Personal Protective Equipment 01/2022
1	Donor Selection 01/2021
1	Neonatal Intensive Care 01/2021
1	Secondary Prevention 01/2021
1	Fecal Microbiota Transplantation 01/2021
1	Transplantation 01/2020
1	Parenteral Nutrition 01/2020
1	Glycemic Control 01/2017
1	Tracheostomy 10/2016
1	Punctures 05/2010